GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B2245 BRL-54443Summary: 5-HT1E/1F receptor agonist,potent and selective -
B1426 Org 27569Target: CB1 ReceptorsSummary: Cannabinoid CB1 receptor allosteric modulator -
B1792 Montelukast SodiumSummary: Leukotriene receptor antagonist -
B1896 BetamethasoneSummary: Glucocorticoid receptor agonist -
B1248 Beclomethasone dipropionateSummary: Corticosteroid used for asthma and rhinitis -
B1900 Budesonide1 CitationSummary: Anti-inflammatory corticosteroid -
B1511 Mifepristone11 CitationTarget: Progesterone Receptors|Glucocorticoid ReceptorsSummary: Progesterone receptor antagonist -
B1004 ICI 118,551 hydrochlorideSummary: Highly selective β2 adrenergic receptor antagonist -
B1429 Rimonabant6 CitationTarget: CB1 Receptors|CB2 ReceptorsSummary: CB1 receptor antagonist -
B1198 CisaprideTarget: Voltage-gated Potassium (KV) Channels|5-HT4 ReceptorSummary: 5-HT4 receptor agonist
